RAMM Pharma Corp. (CSE:RAMM)
Canada · Delayed Price · Currency is CAD 0.0150
+0.0050 (50.00%)
Oct 7, 2025, 10:17 AM EDT
RAMM Pharma Revenue
RAMM Pharma had revenue of 883.22K CAD in the quarter ending July 31, 2025, a decrease of -26.89%. This brings the company's revenue in the last twelve months to 3.78M, down -15.51% year-over-year. In the fiscal year ending October 31, 2024, RAMM Pharma had annual revenue of 4.34M, down -14.28%.
Revenue (ttm)
3.78M
Revenue Growth
-15.51%
P/S Ratio
0.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 4.34M | -723.29K | -14.28% |
| Oct 31, 2023 | 5.07M | 1.17M | 29.96% |
| Oct 31, 2022 | 3.90M | -218.63K | -5.31% |
| Oct 31, 2021 | 4.12M | -1.33M | -24.40% |
| Oct 31, 2020 | 5.44M | -165.89K | -2.96% |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| Green Thumb Industries | 1.57B |
| Trulieve Cannabis | 1.62B |
| dentalcorp Holdings | 1.62B |
| Sienna Senior Living | 929.68M |
| WELL Health Technologies | 1.12B |
| Cronos Group | 177.69M |
| Extendicare | 1.51B |